Novel motif:83: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:58, 9 September 2013
name: | motif83_TTWTAAA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0009888 | tissue development | 3.551588e-25 |
GO:0050896 | response to stimulus | 4.653115e-24 |
GO:0048513 | organ development | 8.758533e-24 |
GO:0050794 | regulation of cellular process | 6.544777e-22 |
GO:0051716 | cellular response to stimulus | 2.006815e-21 |
GO:0048856 | anatomical structure development | 2.537354e-21 |
GO:0009611 | response to wounding | 1.228801e-20 |
GO:0048731 | system development | 4.463085e-20 |
GO:0032501 | multicellular organismal process | 1.201389e-19 |
GO:0032502 | developmental process | 1.425628e-18 |
GO:0042060 | wound healing | 7.758746e-18 |
GO:0042221 | response to chemical stimulus | 1.749544e-17 |
GO:0023052 | signaling | 5.373977e-17 |
GO:0065007 | biological regulation | 9.537781e-17 |
GO:0050789 | regulation of biological process | 3.424274e-16 |
GO:0007154 | cell communication | 3.748412e-16 |
GO:0006950 | response to stress | 5.903522e-16 |
GO:0072358 | cardiovascular system development | 1.409016e-15 |
GO:0007275 | multicellular organismal development | 1.730396e-15 |
GO:0030240 | skeletal muscle thin filament assembly | 2.551806e-15 |
GO:0007165 | signal transduction | 4.129891e-15 |
GO:0048468 | cell development | 4.304755e-15 |
GO:0048869 | cellular developmental process | 1.349486e-14 |
GO:0065008 | regulation of biological quality | 1.357532e-14 |
GO:0030154 | cell differentiation | 3.255434e-14 |
GO:0048769 | sarcomerogenesis | 5.630784e-14 |
GO:0051179 | localization | 2.346855e-13 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 2.403131e-13 |
GO:0055003 | cardiac myofibril assembly | 6.863913e-13 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 6.994608e-13 |
GO:0007517 | muscle organ development | 7.088931e-13 |
GO:0014706 | striated muscle tissue development | 2.164649e-12 |
GO:0035051 | cardiac cell differentiation | 4.199618e-12 |
GO:0007596 | blood coagulation | 6.658973e-12 |
GO:0008152 | metabolic process | 6.945779e-12 |
GO:0019220 | regulation of phosphate metabolic process | 7.829675e-12 |
GO:0060537 | muscle tissue development | 9.104777e-12 |
GO:0007599 | hemostasis | 1.063189e-11 |
GO:0007076 | mitotic chromosome condensation | 1.305065e-11 |
GO:0002576 | platelet degranulation | 1.446914e-11 |
GO:0044237 | cellular metabolic process | 2.073130e-11 |
GO:0007166 | cell surface receptor linked signaling pathway | 2.107537e-11 |
GO:0006810 | transport | 2.913534e-11 |
GO:0001775 | cell activation | 3.276813e-11 |
GO:0003008 | system process | 3.661491e-11 |
GO:0014866 | skeletal myofibril assembly | 3.664658e-11 |
GO:0009987 | cellular process | 4.101427e-11 |
GO:0032989 | cellular component morphogenesis | 4.469110e-11 |
GO:0061061 | muscle structure development | 4.999407e-11 |
GO:0050878 | regulation of body fluid levels | 5.750633e-11 |
GO:0042325 | regulation of phosphorylation | 6.322178e-11 |
GO:0044260 | cellular macromolecule metabolic process | 7.035468e-11 |
GO:0050793 | regulation of developmental process | 1.004258e-10 |
GO:0051234 | establishment of localization | 1.039396e-10 |
GO:0018149 | peptide cross-linking | 1.450698e-10 |
GO:0048583 | regulation of response to stimulus | 1.604051e-10 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 1.616671e-10 |
GO:0007507 | heart development | 1.619039e-10 |
GO:0045663 | positive regulation of myoblast differentiation | 1.810223e-10 |
GO:0048729 | tissue morphogenesis | 2.092042e-10 |
GO:0055007 | cardiac muscle cell differentiation | 2.443734e-10 |
GO:0001932 | regulation of protein phosphorylation | 2.917453e-10 |
GO:0009653 | anatomical structure morphogenesis | 3.352689e-10 |
GO:0045666 | positive regulation of neuron differentiation | 5.636125e-10 |
GO:0003007 | heart morphogenesis | 9.630628e-10 |
GO:0044238 | primary metabolic process | 1.225777e-9 |
GO:0001944 | vasculature development | 1.304923e-9 |
GO:0071559 | response to transforming growth factor beta stimulus | 1.327890e-9 |
GO:0070887 | cellular response to chemical stimulus | 1.467830e-9 |
GO:0055013 | cardiac muscle cell development | 1.806459e-9 |
GO:0010033 | response to organic substance | 1.847040e-9 |
GO:0001568 | blood vessel development | 3.140864e-9 |
GO:0007399 | nervous system development | 3.170511e-9 |
GO:0043170 | macromolecule metabolic process | 3.177740e-9 |
GO:0007417 | central nervous system development | 3.191571e-9 |
GO:0051592 | response to calcium ion | 3.365786e-9 |
GO:0043438 | acetoacetic acid metabolic process | 3.405098e-9 |
GO:0019605 | butyrate metabolic process | 3.421044e-9 |
GO:2000026 | regulation of multicellular organismal development | 3.494765e-9 |
GO:0000070 | mitotic sister chromatid segregation | 3.972937e-9 |
GO:0045137 | development of primary sexual characteristics | 4.046719e-9 |
GO:0000819 | sister chromatid segregation | 4.836334e-9 |
GO:0048608 | reproductive structure development | 5.766682e-9 |
GO:0045597 | positive regulation of cell differentiation | 5.932771e-9 |
GO:0010863 | positive regulation of phospholipase C activity | 7.394416e-9 |
GO:0016202 | regulation of striated muscle tissue development | 7.466101e-9 |
GO:0010038 | response to metal ion | 7.754398e-9 |
GO:0060736 | prostate gland growth | 8.375847e-9 |
GO:0071842 | cellular component organization at cellular level | 8.414952e-9 |
GO:0030168 | platelet activation | 8.628212e-9 |
GO:0006629 | lipid metabolic process | 1.210012e-8 |
GO:0007420 | brain development | 1.253262e-8 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 1.325264e-8 |
GO:0007160 | cell-matrix adhesion | 1.493106e-8 |
GO:0010517 | regulation of phospholipase activity | 1.670355e-8 |
GO:0007202 | activation of phospholipase C activity | 1.802726e-8 |
GO:0016043 | cellular component organization | 1.851868e-8 |
GO:0001655 | urogenital system development | 2.150698e-8 |
GO:0032268 | regulation of cellular protein metabolic process | 2.217667e-8 |
GO:0033036 | macromolecule localization | 2.287681e-8 |
GO:0015721 | bile acid and bile salt transport | 2.307198e-8 |
GO:0051094 | positive regulation of developmental process | 2.332536e-8 |
GO:0042438 | melanin biosynthetic process | 2.402922e-8 |
GO:0008285 | negative regulation of cell proliferation | 2.416423e-8 |
GO:0048634 | regulation of muscle organ development | 2.679116e-8 |
GO:0009719 | response to endogenous stimulus | 2.792187e-8 |
GO:0071495 | cellular response to endogenous stimulus | 3.629845e-8 |
GO:0007267 | cell-cell signaling | 4.048298e-8 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 4.095888e-8 |
GO:0031399 | regulation of protein modification process | 4.332299e-8 |
GO:0030850 | prostate gland development | 4.732176e-8 |
GO:0071840 | cellular component organization or biogenesis | 5.191651e-8 |
GO:0045214 | sarcomere organization | 5.740038e-8 |
GO:0006068 | ethanol catabolic process | 5.872439e-8 |
GO:0045595 | regulation of cell differentiation | 6.168795e-8 |
GO:0030199 | collagen fibril organization | 7.425860e-8 |
GO:0046459 | short-chain fatty acid metabolic process | 8.564473e-8 |
GO:0008104 | protein localization | 9.205904e-8 |
GO:0000902 | cell morphogenesis | 9.546088e-8 |
GO:0060740 | prostate gland epithelium morphogenesis | 9.592316e-8 |
GO:0006582 | melanin metabolic process | 9.966122e-8 |
GO:0048522 | positive regulation of cellular process | 1.092869e-7 |
GO:0010518 | positive regulation of phospholipase activity | 1.232675e-7 |
GO:0008406 | gonad development | 1.236503e-7 |
GO:0048565 | digestive tract development | 1.295833e-7 |
GO:0060068 | vagina development | 1.440072e-7 |
GO:0046546 | development of primary male sexual characteristics | 1.477159e-7 |
GO:0031323 | regulation of cellular metabolic process | 1.657193e-7 |
GO:0060512 | prostate gland morphogenesis | 1.746795e-7 |
GO:0060429 | epithelium development | 1.761862e-7 |
GO:0060011 | Sertoli cell proliferation | 1.762158e-7 |
GO:0044255 | cellular lipid metabolic process | 2.029984e-7 |
GO:0033382 | maintenance of granzyme B location in T cell secretory granule | 2.089969e-7 |
GO:0033373 | maintenance of protease location in mast cell secretory granule | 2.089969e-7 |
GO:0048747 | muscle fiber development | 2.147056e-7 |
GO:0051970 | negative regulation of transmission of nerve impulse | 2.234675e-7 |
GO:0072507 | divalent inorganic cation homeostasis | 2.372249e-7 |
GO:0045661 | regulation of myoblast differentiation | 2.502020e-7 |
GO:0019748 | secondary metabolic process | 2.506535e-7 |
GO:2000739 | regulation of mesenchymal stem cell differentiation | 2.530189e-7 |
GO:0060191 | regulation of lipase activity | 2.539008e-7 |
GO:0048519 | negative regulation of biological process | 2.663678e-7 |
GO:0006805 | xenobiotic metabolic process | 2.764375e-7 |
GO:0019222 | regulation of metabolic process | 2.824935e-7 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.843130e-7 |
GO:0022008 | neurogenesis | 2.912170e-7 |
GO:0048699 | generation of neurons | 2.967507e-7 |
GO:0051153 | regulation of striated muscle cell differentiation | 2.975380e-7 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 3.017372e-7 |
GO:0030182 | neuron differentiation | 3.240960e-7 |
GO:0043408 | regulation of MAPKKK cascade | 3.486031e-7 |
GO:0007548 | sex differentiation | 3.572238e-7 |
GO:0045785 | positive regulation of cell adhesion | 3.633868e-7 |
GO:0048589 | developmental growth | 3.807540e-7 |
GO:0007519 | skeletal muscle tissue development | 3.924351e-7 |
GO:0032514 | positive regulation of protein phosphatase type 2B activity | 4.071368e-7 |
GO:0048742 | regulation of skeletal muscle fiber development | 4.327328e-7 |
GO:0006029 | proteoglycan metabolic process | 4.520583e-7 |
GO:0051239 | regulation of multicellular organismal process | 4.559020e-7 |
GO:0031032 | actomyosin structure organization | 4.622593e-7 |
GO:0010811 | positive regulation of cell-substrate adhesion | 4.632626e-7 |
GO:0048523 | negative regulation of cellular process | 4.680169e-7 |
GO:0009966 | regulation of signal transduction | 4.805516e-7 |
GO:0014031 | mesenchymal cell development | 4.811027e-7 |
GO:0071103 | DNA conformation change | 5.069608e-7 |
GO:0043473 | pigmentation | 5.656090e-7 |
GO:0006887 | exocytosis | 5.784980e-7 |
GO:0030098 | lymphocyte differentiation | 5.804211e-7 |
GO:0006464 | protein modification process | 5.957899e-7 |
GO:0055074 | calcium ion homeostasis | 6.123228e-7 |
GO:0060193 | positive regulation of lipase activity | 6.189771e-7 |
GO:0009410 | response to xenobiotic stimulus | 6.408296e-7 |
GO:0042692 | muscle cell differentiation | 6.543053e-7 |
GO:0048518 | positive regulation of biological process | 6.610914e-7 |
GO:0023051 | regulation of signaling | 6.862624e-7 |
GO:0050805 | negative regulation of synaptic transmission | 7.182017e-7 |
GO:0048066 | developmental pigmentation | 7.424854e-7 |
GO:0071466 | cellular response to xenobiotic stimulus | 7.558034e-7 |
GO:0048514 | blood vessel morphogenesis | 7.785418e-7 |
GO:0090286 | cytoskeletal anchoring at nuclear membrane | 7.943550e-7 |
GO:0048739 | cardiac muscle fiber development | 8.672025e-7 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 9.505773e-7 |
GO:0048641 | regulation of skeletal muscle tissue development | 1.151339e-6 |
GO:0009617 | response to bacterium | 1.259509e-6 |
GO:0031645 | negative regulation of neurological system process | 1.302479e-6 |
GO:0002520 | immune system development | 1.420160e-6 |
GO:0000186 | activation of MAPKK activity | 1.474268e-6 |
GO:0010927 | cellular component assembly involved in morphogenesis | 1.518261e-6 |
GO:0051641 | cellular localization | 1.564813e-6 |
GO:0016567 | protein ubiquitination | 1.575370e-6 |
GO:0042246 | tissue regeneration | 1.685325e-6 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 1.687894e-6 |
GO:0072503 | cellular divalent inorganic cation homeostasis | 1.718222e-6 |
GO:0042113 | B cell activation | 1.740664e-6 |
GO:0031589 | cell-substrate adhesion | 1.761183e-6 |
GO:0055002 | striated muscle cell development | 1.821822e-6 |
GO:0046826 | negative regulation of protein export from nucleus | 1.829829e-6 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1.877538e-6 |
GO:0007059 | chromosome segregation | 2.037636e-6 |
GO:0008584 | male gonad development | 2.137507e-6 |
GO:0030183 | B cell differentiation | 2.281777e-6 |
GO:0090270 | regulation of fibroblast growth factor production | 2.368011e-6 |
GO:0016331 | morphogenesis of embryonic epithelium | 2.420619e-6 |
GO:0001841 | neural tube formation | 2.487272e-6 |
GO:0070493 | thrombin receptor signaling pathway | 2.605488e-6 |
GO:0043412 | macromolecule modification | 2.633659e-6 |
GO:0055123 | digestive system development | 2.701017e-6 |
GO:0044267 | cellular protein metabolic process | 2.715892e-6 |
GO:0008038 | neuron recognition | 2.743701e-6 |
GO:0046661 | male sex differentiation | 2.765999e-6 |
GO:0060255 | regulation of macromolecule metabolic process | 2.782481e-6 |
GO:0032940 | secretion by cell | 2.894254e-6 |
GO:0002009 | morphogenesis of an epithelium | 2.944917e-6 |
GO:0055114 | oxidation-reduction process | 2.987745e-6 |
GO:0019932 | second-messenger-mediated signaling | 3.020724e-6 |
GO:0042127 | regulation of cell proliferation | 3.122131e-6 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 3.209391e-6 |
GO:0007368 | determination of left/right symmetry | 3.217967e-6 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 3.522422e-6 |
GO:0060538 | skeletal muscle organ development | 3.586822e-6 |
GO:0008202 | steroid metabolic process | 3.677006e-6 |
GO:0060317 | cardiac epithelial to mesenchymal transition | 3.721343e-6 |
GO:0051338 | regulation of transferase activity | 3.970158e-6 |
GO:0006874 | cellular calcium ion homeostasis | 3.998712e-6 |
GO:0035115 | embryonic forelimb morphogenesis | 4.177442e-6 |
GO:0032147 | activation of protein kinase activity | 4.245376e-6 |
GO:0048762 | mesenchymal cell differentiation | 4.260871e-6 |
GO:0040011 | locomotion | 4.419944e-6 |
GO:0055008 | cardiac muscle tissue morphogenesis | 4.439565e-6 |
GO:0001654 | eye development | 4.503487e-6 |
GO:0090292 | nuclear matrix anchoring at nuclear membrane | 4.541866e-6 |
GO:0070252 | actin-mediated cell contraction | 4.553161e-6 |
GO:0032879 | regulation of localization | 4.648341e-6 |
GO:0048534 | hemopoietic or lymphoid organ development | 4.658971e-6 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 5.016365e-6 |
GO:0030097 | hemopoiesis | 5.138619e-6 |
GO:0080090 | regulation of primary metabolic process | 5.575887e-6 |
GO:0048738 | cardiac muscle tissue development | 5.653792e-6 |
GO:0000904 | cell morphogenesis involved in differentiation | 5.677554e-6 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 5.879934e-6 |
GO:0045664 | regulation of neuron differentiation | 5.913462e-6 |
GO:0060442 | branching involved in prostate gland morphogenesis | 6.025975e-6 |
GO:0032870 | cellular response to hormone stimulus | 6.144985e-6 |
GO:0042180 | cellular ketone metabolic process | 6.174293e-6 |
GO:0045165 | cell fate commitment | 6.432427e-6 |
GO:0032990 | cell part morphogenesis | 6.515618e-6 |
GO:0060525 | prostate glandular acinus development | 6.516101e-6 |
GO:0060284 | regulation of cell development | 7.144269e-6 |
GO:0006796 | phosphate-containing compound metabolic process | 7.215931e-6 |
GO:0003401 | axis elongation | 7.241794e-6 |
GO:0007229 | integrin-mediated signaling pathway | 7.973585e-6 |
GO:0014910 | regulation of smooth muscle cell migration | 8.004591e-6 |
GO:0006928 | cellular component movement | 8.080288e-6 |
GO:0061008 | hepaticobiliary system development | 8.128346e-6 |
GO:0055080 | cation homeostasis | 8.462439e-6 |
GO:0046836 | glycolipid transport | 8.844050e-6 |
GO:0090304 | nucleic acid metabolic process | 8.881122e-6 |
GO:0065009 | regulation of molecular function | 8.974800e-6 |
GO:0009799 | specification of symmetry | 9.123827e-6 |
GO:0060737 | prostate gland morphogenetic growth | 9.140365e-6 |
GO:0032446 | protein modification by small protein conjugation | 9.141884e-6 |
GO:0048858 | cell projection morphogenesis | 9.226558e-6 |
GO:0009855 | determination of bilateral symmetry | 9.530115e-6 |
GO:0007040 | lysosome organization | 9.551555e-6 |
GO:0030261 | chromosome condensation | 9.793592e-6 |
GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 9.847942e-6 |
GO:0080135 | regulation of cellular response to stress | 9.939643e-6 |
GO:0009887 | organ morphogenesis | 1.009613e-5 |
GO:0009725 | response to hormone stimulus | 1.041536e-5 |
GO:0002376 | immune system process | 1.048775e-5 |
GO:0003006 | developmental process involved in reproduction | 1.071390e-5 |
GO:0051480 | cytosolic calcium ion homeostasis | 1.103587e-5 |
GO:0061036 | positive regulation of cartilage development | 1.113581e-5 |
GO:0040012 | regulation of locomotion | 1.138834e-5 |
GO:0043549 | regulation of kinase activity | 1.248514e-5 |
GO:0007033 | vacuole organization | 1.262600e-5 |
GO:0050877 | neurological system process | 1.268006e-5 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 1.304751e-5 |
GO:0030049 | muscle filament sliding | 1.340107e-5 |
GO:0009593 | detection of chemical stimulus | 1.431681e-5 |
GO:0021915 | neural tube development | 1.436045e-5 |
GO:0051146 | striated muscle cell differentiation | 1.437014e-5 |
GO:0006954 | inflammatory response | 1.438801e-5 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.510851e-5 |
GO:0033059 | cellular pigmentation | 1.521623e-5 |
GO:0048709 | oligodendrocyte differentiation | 1.546073e-5 |
GO:0009893 | positive regulation of metabolic process | 1.552840e-5 |
GO:0002683 | negative regulation of immune system process | 1.563328e-5 |
GO:0016198 | axon choice point recognition | 1.676140e-5 |
GO:0030239 | myofibril assembly | 1.693387e-5 |
GO:0050931 | pigment cell differentiation | 1.697919e-5 |
GO:0019752 | carboxylic acid metabolic process | 1.721326e-5 |
GO:0001889 | liver development | 1.745415e-5 |
GO:0001525 | angiogenesis | 1.751561e-5 |
GO:0060383 | positive regulation of DNA strand elongation | 1.810811e-5 |
GO:0032332 | positive regulation of chondrocyte differentiation | 1.906757e-5 |
GO:0060415 | muscle tissue morphogenesis | 1.945945e-5 |
GO:0010627 | regulation of intracellular protein kinase cascade | 2.003770e-5 |
GO:0006935 | chemotaxis | 2.167698e-5 |
GO:0060602 | branch elongation of an epithelium | 2.179386e-5 |
GO:0001838 | embryonic epithelial tube formation | 2.227898e-5 |
GO:0050790 | regulation of catalytic activity | 2.264303e-5 |
GO:0006082 | organic acid metabolic process | 2.298842e-5 |
GO:2000145 | regulation of cell motility | 2.314707e-5 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 2.322915e-5 |
GO:0006323 | DNA packaging | 2.324792e-5 |
GO:0014033 | neural crest cell differentiation | 2.324822e-5 |
GO:0048584 | positive regulation of response to stimulus | 2.352731e-5 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 2.361000e-5 |
GO:0002430 | complement receptor mediated signaling pathway | 2.401372e-5 |
GO:0006952 | defense response | 2.462095e-5 |
GO:0010646 | regulation of cell communication | 2.463835e-5 |
GO:0048015 | phosphatidylinositol-mediated signaling | 2.487111e-5 |
GO:0055001 | muscle cell development | 2.513688e-5 |
GO:0070848 | response to growth factor stimulus | 2.546190e-5 |
GO:0047496 | vesicle transport along microtubule | 2.579558e-5 |
GO:0030728 | ovulation | 2.586747e-5 |
GO:0008206 | bile acid metabolic process | 2.671461e-5 |
GO:0008228 | opsonization | 2.696530e-5 |
GO:0044344 | cellular response to fibroblast growth factor stimulus | 2.727688e-5 |
GO:0060523 | prostate epithelial cord elongation | 2.781204e-5 |
GO:0090336 | positive regulation of brown fat cell differentiation | 2.797078e-5 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 2.797078e-5 |
GO:0090271 | positive regulation of fibroblast growth factor production | 2.797078e-5 |
GO:0055065 | metal ion homeostasis | 2.802318e-5 |
GO:0045070 | positive regulation of viral genome replication | 2.859954e-5 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 2.864805e-5 |
GO:0007155 | cell adhesion | 2.870882e-5 |
GO:0010810 | regulation of cell-substrate adhesion | 2.922887e-5 |
GO:0006720 | isoprenoid metabolic process | 2.975333e-5 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 2.982121e-5 |
GO:0006833 | water transport | 3.018403e-5 |
GO:0032438 | melanosome organization | 3.131792e-5 |
GO:0051345 | positive regulation of hydrolase activity | 3.157173e-5 |
GO:0009072 | aromatic amino acid family metabolic process | 3.300016e-5 |
GO:0015722 | canalicular bile acid transport | 3.334912e-5 |
GO:0048812 | neuron projection morphogenesis | 3.373184e-5 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 3.407772e-5 |
GO:0001764 | neuron migration | 3.423227e-5 |
GO:0006069 | ethanol oxidation | 3.608178e-5 |
GO:0022602 | ovulation cycle process | 3.622450e-5 |
GO:0048592 | eye morphogenesis | 3.662490e-5 |
GO:0046903 | secretion | 3.688261e-5 |
GO:0060174 | limb bud formation | 3.798287e-5 |
GO:0040017 | positive regulation of locomotion | 3.824584e-5 |
GO:0048878 | chemical homeostasis | 3.894917e-5 |
GO:0072175 | epithelial tube formation | 4.051711e-5 |
GO:0071310 | cellular response to organic substance | 4.080926e-5 |
GO:0002070 | epithelial cell maturation | 4.112256e-5 |
GO:0060485 | mesenchyme development | 4.216604e-5 |
GO:0042044 | fluid transport | 4.233251e-5 |
GO:0007525 | somatic muscle development | 4.446122e-5 |
GO:0097070 | ductus arteriosus closure | 4.542649e-5 |
GO:0051149 | positive regulation of muscle cell differentiation | 4.657718e-5 |
GO:0061033 | secretion by lung epithelial cell involved in lung growth | 4.700756e-5 |
GO:0010838 | positive regulation of keratinocyte proliferation | 4.700756e-5 |
GO:0032512 | regulation of protein phosphatase type 2B activity | 4.700756e-5 |
GO:0030155 | regulation of cell adhesion | 4.708154e-5 |
GO:0010604 | positive regulation of macromolecule metabolic process | 4.718211e-5 |
GO:0030900 | forebrain development | 5.029743e-5 |
GO:0001708 | cell fate specification | 5.063695e-5 |
GO:0035058 | nonmotile primary cilium assembly | 5.192886e-5 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 5.266235e-5 |
GO:0030204 | chondroitin sulfate metabolic process | 5.269023e-5 |
GO:0048753 | pigment granule organization | 5.342957e-5 |
GO:0045185 | maintenance of protein location | 5.480016e-5 |
GO:0009820 | alkaloid metabolic process | 5.563771e-5 |
GO:0060548 | negative regulation of cell death | 5.652480e-5 |
GO:0035556 | intracellular signal transduction | 5.674565e-5 |
GO:0006721 | terpenoid metabolic process | 5.774330e-5 |
GO:0008037 | cell recognition | 5.838946e-5 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 5.841438e-5 |
GO:0051046 | regulation of secretion | 5.916874e-5 |
GO:0042698 | ovulation cycle | 5.932312e-5 |
GO:0050906 | detection of stimulus involved in sensory perception | 5.983487e-5 |
GO:0070168 | negative regulation of biomineral tissue development | 6.408830e-5 |
GO:0035136 | forelimb morphogenesis | 6.421871e-5 |
GO:0035148 | tube formation | 6.454541e-5 |
GO:0060638 | mesenchymal-epithelial cell signaling | 6.519538e-5 |
GO:0030003 | cellular cation homeostasis | 6.558063e-5 |
GO:0031325 | positive regulation of cellular metabolic process | 6.764966e-5 |
GO:0045923 | positive regulation of fatty acid metabolic process | 7.000653e-5 |
GO:0002521 | leukocyte differentiation | 7.156442e-5 |
GO:0001947 | heart looping | 7.181175e-5 |
GO:0071305 | cellular response to vitamin D | 7.501416e-5 |
GO:0051602 | response to electrical stimulus | 7.559681e-5 |
GO:0006875 | cellular metal ion homeostasis | 7.819105e-5 |
GO:0030335 | positive regulation of cell migration | 7.893920e-5 |
GO:0051649 | establishment of localization in cell | 8.193971e-5 |
GO:0032787 | monocarboxylic acid metabolic process | 8.383226e-5 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 8.475708e-5 |
GO:0051246 | regulation of protein metabolic process | 8.549443e-5 |
GO:0006775 | fat-soluble vitamin metabolic process | 8.608472e-5 |
GO:0055082 | cellular chemical homeostasis | 8.649194e-5 |
GO:0016477 | cell migration | 8.701670e-5 |
GO:0030334 | regulation of cell migration | 8.831311e-5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 9.011489e-5 |
GO:0072383 | plus-end-directed vesicle transport along microtubule | 9.082390e-5 |
GO:0006072 | glycerol-3-phosphate metabolic process | 9.135022e-5 |
GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste | 9.246467e-5 |
GO:0045859 | regulation of protein kinase activity | 9.247019e-5 |
GO:0051336 | regulation of hydrolase activity | 9.363468e-5 |
GO:0072001 | renal system development | 9.440137e-5 |
GO:0016310 | phosphorylation | 9.465372e-5 |
GO:0010648 | negative regulation of cell communication | 9.778437e-5 |
GO:0007389 | pattern specification process | 1.020983e-4 |
GO:0060606 | tube closure | 1.038070e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.047743e-4 |
GO:0030522 | intracellular receptor mediated signaling pathway | 1.048071e-4 |
GO:0014032 | neural crest cell development | 1.080511e-4 |
GO:0032252 | secretory granule localization | 1.094796e-4 |
GO:0006583 | melanin biosynthetic process from tyrosine | 1.101486e-4 |
GO:0051270 | regulation of cellular component movement | 1.107758e-4 |
GO:2000027 | regulation of organ morphogenesis | 1.126159e-4 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 1.149557e-4 |
GO:0046649 | lymphocyte activation | 1.176389e-4 |
GO:0010001 | glial cell differentiation | 1.176410e-4 |
GO:0023057 | negative regulation of signaling | 1.178095e-4 |
GO:0030048 | actin filament-based movement | 1.180601e-4 |
GO:0007618 | mating | 1.190859e-4 |
GO:0023056 | positive regulation of signaling | 1.230843e-4 |
GO:0051235 | maintenance of location | 1.232225e-4 |
GO:0030203 | glycosaminoglycan metabolic process | 1.239935e-4 |
GO:0006468 | protein phosphorylation | 1.243525e-4 |
GO:0048806 | genitalia development | 1.258903e-4 |
GO:0001843 | neural tube closure | 1.365500e-4 |
GO:2000147 | positive regulation of cell motility | 1.372290e-4 |
GO:0051272 | positive regulation of cellular component movement | 1.377696e-4 |
GO:0030502 | negative regulation of bone mineralization | 1.393001e-4 |
GO:0007567 | parturition | 1.406797e-4 |
GO:0003014 | renal system process | 1.412343e-4 |
GO:0043069 | negative regulation of programmed cell death | 1.422757e-4 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 1.430217e-4 |
GO:0048870 | cell motility | 1.432750e-4 |
GO:0032330 | regulation of chondrocyte differentiation | 1.473830e-4 |
GO:0021953 | central nervous system neuron differentiation | 1.486465e-4 |
GO:0060008 | Sertoli cell differentiation | 1.493107e-4 |
GO:0046292 | formaldehyde metabolic process | 1.500579e-4 |
GO:0007409 | axonogenesis | 1.501090e-4 |
GO:0046328 | regulation of JNK cascade | 1.531606e-4 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 1.541700e-4 |
GO:0021778 | oligodendrocyte cell fate specification | 1.550726e-4 |
GO:0043066 | negative regulation of apoptosis | 1.581863e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.613776e-4 |
GO:0010232 | vascular transport | 1.644742e-4 |
GO:0006426 | glycyl-tRNA aminoacylation | 1.644742e-4 |
GO:0003408 | optic cup formation involved in camera-type eye development | 1.676050e-4 |
GO:0014912 | negative regulation of smooth muscle cell migration | 1.719169e-4 |
GO:0042063 | gliogenesis | 1.722112e-4 |
GO:0048683 | regulation of collateral sprouting of intact axon in response to injury | 1.779646e-4 |
GO:0032227 | negative regulation of synaptic transmission, dopaminergic | 1.779646e-4 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 1.781153e-4 |
GO:0051704 | multi-organism process | 1.837508e-4 |
GO:0052697 | xenobiotic glucuronidation | 1.837693e-4 |
GO:0070980 | biphenyl catabolic process | 1.837693e-4 |
GO:0051552 | flavone metabolic process | 1.837693e-4 |
GO:0052696 | flavonoid glucuronidation | 1.837693e-4 |
GO:0006789 | bilirubin conjugation | 1.837693e-4 |
GO:0051276 | chromosome organization | 1.838648e-4 |
GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 1.892235e-4 |
GO:0050869 | negative regulation of B cell activation | 1.893842e-4 |
GO:0007600 | sensory perception | 1.922960e-4 |
GO:0010647 | positive regulation of cell communication | 1.950825e-4 |
GO:0021517 | ventral spinal cord development | 1.977494e-4 |
GO:0014020 | primary neural tube formation | 2.007932e-4 |
GO:0009083 | branched chain family amino acid catabolic process | 2.054851e-4 |
GO:0046854 | phosphatidylinositol phosphorylation | 2.069914e-4 |
GO:0015701 | bicarbonate transport | 2.080958e-4 |
GO:0051705 | behavioral interaction between organisms | 2.121376e-4 |
GO:0017144 | drug metabolic process | 2.177293e-4 |
GO:0042572 | retinol metabolic process | 2.226333e-4 |
GO:0009063 | cellular amino acid catabolic process | 2.248904e-4 |
GO:0050801 | ion homeostasis | 2.253785e-4 |
GO:0006916 | anti-apoptosis | 2.297629e-4 |
GO:0007030 | Golgi organization | 2.305892e-4 |
GO:0006807 | nitrogen compound metabolic process | 2.342604e-4 |
GO:0060900 | embryonic camera-type eye formation | 2.389179e-4 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 2.403357e-4 |
GO:0014911 | positive regulation of smooth muscle cell migration | 2.496165e-4 |
GO:0045767 | regulation of anti-apoptosis | 2.497129e-4 |
GO:0030318 | melanocyte differentiation | 2.557519e-4 |
GO:0051147 | regulation of muscle cell differentiation | 2.602976e-4 |
GO:0060562 | epithelial tube morphogenesis | 2.607300e-4 |
GO:0019441 | tryptophan catabolic process to kynurenine | 2.653683e-4 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 2.681907e-4 |
GO:0001822 | kidney development | 2.715645e-4 |
GO:0015031 | protein transport | 2.762266e-4 |
GO:0045884 | regulation of survival gene product expression | 2.858345e-4 |
GO:0060629 | regulation of homologous chromosome segregation | 2.876728e-4 |
GO:0051598 | meiotic recombination checkpoint | 2.876728e-4 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.938873e-4 |
GO:0009081 | branched chain family amino acid metabolic process | 2.958390e-4 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 3.046129e-4 |
GO:0010834 | telomere maintenance via telomere shortening | 3.068912e-4 |
GO:0009435 | NAD biosynthetic process | 3.149828e-4 |
GO:0019538 | protein metabolic process | 3.175918e-4 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 3.197546e-4 |
GO:0007157 | heterophilic cell-cell adhesion | 3.240413e-4 |
GO:0007156 | homophilic cell adhesion | 3.251453e-4 |
GO:0046329 | negative regulation of JNK cascade | 3.266290e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048513 | organ development | 1.808976e-13 |
GO:0048731 | system development | 4.299585e-10 |
GO:0048034 | heme O biosynthetic process | 4.638166e-10 |
GO:0002376 | immune system process | 1.118989e-9 |
GO:0048856 | anatomical structure development | 1.250776e-9 |
GO:0032817 | regulation of natural killer cell proliferation | 1.907130e-9 |
GO:0045321 | leukocyte activation | 2.899822e-9 |
GO:0006955 | immune response | 3.784219e-9 |
GO:0006014 | D-ribose metabolic process | 4.641627e-9 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 4.877888e-9 |
GO:0007275 | multicellular organismal development | 5.639174e-9 |
GO:0045445 | myoblast differentiation | 6.396210e-9 |
GO:0019693 | ribose phosphate metabolic process | 8.007014e-9 |
GO:0032502 | developmental process | 9.833989e-9 |
GO:0048584 | positive regulation of response to stimulus | 4.486255e-8 |
GO:0035295 | tube development | 4.637171e-8 |
GO:0043129 | surfactant homeostasis | 6.277334e-8 |
GO:0046649 | lymphocyte activation | 1.241560e-7 |
GO:0032501 | multicellular organismal process | 1.597222e-7 |
GO:0017004 | cytochrome complex assembly | 1.700353e-7 |
GO:0001775 | cell activation | 2.130608e-7 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 2.348842e-7 |
GO:0043620 | regulation of DNA-dependent transcription in response to stress | 2.707415e-7 |
GO:0048520 | positive regulation of behavior | 4.152300e-7 |
GO:0050793 | regulation of developmental process | 5.337070e-7 |
GO:0032814 | regulation of natural killer cell activation | 6.289594e-7 |
GO:0045671 | negative regulation of osteoclast differentiation | 7.261108e-7 |
GO:0050930 | induction of positive chemotaxis | 7.543516e-7 |
GO:0006704 | glucocorticoid biosynthetic process | 8.932113e-7 |
GO:0050801 | ion homeostasis | 9.430192e-7 |
GO:0097091 | synaptic vesicle clustering | 9.572910e-7 |
GO:0097105 | presynaptic membrane assembly | 9.928011e-7 |
GO:0048534 | hemopoietic or lymphoid organ development | 1.026295e-6 |
GO:0051648 | vesicle localization | 1.072293e-6 |
GO:0009653 | anatomical structure morphogenesis | 1.179444e-6 |
GO:0002520 | immune system development | 1.211131e-6 |
GO:0007157 | heterophilic cell-cell adhesion | 1.373737e-6 |
GO:0010960 | magnesium ion homeostasis | 1.592705e-6 |
GO:0042110 | T cell activation | 1.651602e-6 |
GO:0030097 | hemopoiesis | 1.740987e-6 |
GO:0007158 | neuron cell-cell adhesion | 2.186516e-6 |
GO:0048869 | cellular developmental process | 2.254392e-6 |
GO:0042098 | T cell proliferation | 2.256846e-6 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 2.352002e-6 |
GO:0030098 | lymphocyte differentiation | 2.389761e-6 |
GO:0060412 | ventricular septum morphogenesis | 2.720274e-6 |
GO:0097090 | presynaptic membrane organization | 2.728061e-6 |
GO:0046651 | lymphocyte proliferation | 3.083682e-6 |
GO:0070661 | leukocyte proliferation | 3.155823e-6 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 3.667395e-6 |
GO:0002683 | negative regulation of immune system process | 3.789359e-6 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 4.111429e-6 |
GO:0035644 | phosphoanandamide dephosphorylation | 4.164330e-6 |
GO:0061053 | somite development | 4.794790e-6 |
GO:0051239 | regulation of multicellular organismal process | 4.910373e-6 |
GO:0016339 | calcium-dependent cell-cell adhesion | 4.998816e-6 |
GO:0043482 | cellular pigment accumulation | 5.270366e-6 |
GO:0006784 | heme a biosynthetic process | 5.843295e-6 |
GO:0097120 | receptor localization to synapse | 6.130990e-6 |
GO:0072578 | neurotransmitter-gated ion channel clustering | 6.130990e-6 |
GO:0016080 | synaptic vesicle targeting | 6.226505e-6 |
GO:0048878 | chemical homeostasis | 6.296007e-6 |
GO:0032943 | mononuclear cell proliferation | 6.598070e-6 |
GO:0030154 | cell differentiation | 6.801223e-6 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 8.913038e-6 |
GO:2001051 | positive regulation of tendon cell differentiation | 8.946924e-6 |
GO:0021509 | roof plate formation | 8.946924e-6 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 9.943506e-6 |
GO:0043496 | regulation of protein homodimerization activity | 1.084445e-5 |
GO:0065008 | regulation of biological quality | 1.115212e-5 |
GO:0008207 | C21-steroid hormone metabolic process | 1.123388e-5 |
GO:0055080 | cation homeostasis | 1.152593e-5 |
GO:0003091 | renal water homeostasis | 1.164546e-5 |
GO:0055065 | metal ion homeostasis | 1.259901e-5 |
GO:0030217 | T cell differentiation | 1.263591e-5 |
GO:0007417 | central nervous system development | 1.287648e-5 |
GO:0048583 | regulation of response to stimulus | 1.289104e-5 |
GO:0006873 | cellular ion homeostasis | 1.331209e-5 |
GO:0051093 | negative regulation of developmental process | 1.488976e-5 |
GO:0002521 | leukocyte differentiation | 1.633281e-5 |
GO:0046620 | regulation of organ growth | 1.754438e-5 |
GO:0043476 | pigment accumulation | 1.792796e-5 |
GO:0050852 | T cell receptor signaling pathway | 1.836945e-5 |
GO:0097104 | postsynaptic membrane assembly | 1.887519e-5 |
GO:0097119 | postsynaptic density protein 95 clustering | 1.887519e-5 |
GO:0034754 | cellular hormone metabolic process | 1.991338e-5 |
GO:0050795 | regulation of behavior | 2.079218e-5 |
GO:0097115 | neurexin clustering | 2.110737e-5 |
GO:0007062 | sister chromatid cohesion | 2.114975e-5 |
GO:0002252 | immune effector process | 2.304594e-5 |
GO:0022602 | ovulation cycle process | 2.459914e-5 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 2.462782e-5 |
GO:0030514 | negative regulation of BMP signaling pathway | 2.648954e-5 |
GO:0032879 | regulation of localization | 2.938275e-5 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 2.977150e-5 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 3.001987e-5 |
GO:0008284 | positive regulation of cell proliferation | 3.029390e-5 |
GO:0055082 | cellular chemical homeostasis | 3.367194e-5 |
GO:0032819 | positive regulation of natural killer cell proliferation | 3.543670e-5 |
GO:0042753 | positive regulation of circadian rhythm | 3.712764e-5 |
GO:0035590 | purinergic nucleotide receptor signaling pathway | 3.806755e-5 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 4.320464e-5 |
GO:0046884 | follicle-stimulating hormone secretion | 4.694974e-5 |
GO:0032275 | luteinizing hormone secretion | 4.694974e-5 |
GO:0030278 | regulation of ossification | 4.737531e-5 |
GO:0090403 | oxidative stress-induced premature senescence | 4.884700e-5 |
GO:0003281 | ventricular septum development | 5.042824e-5 |
GO:0007399 | nervous system development | 5.150153e-5 |
GO:0001756 | somitogenesis | 5.171188e-5 |
GO:0046660 | female sex differentiation | 5.463360e-5 |
GO:0046545 | development of primary female sexual characteristics | 5.536810e-5 |
GO:0051240 | positive regulation of multicellular organismal process | 5.593222e-5 |
GO:0001944 | vasculature development | 5.757016e-5 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 5.806345e-5 |
GO:0009888 | tissue development | 6.026934e-5 |
GO:0045176 | apical protein localization | 6.105322e-5 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 6.271750e-5 |
GO:2000026 | regulation of multicellular organismal development | 6.324755e-5 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 6.358748e-5 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 6.399689e-5 |
GO:0002366 | leukocyte activation involved in immune response | 6.420163e-5 |
GO:0030888 | regulation of B cell proliferation | 6.467017e-5 |
GO:0055081 | anion homeostasis | 6.686304e-5 |
GO:0019321 | pentose metabolic process | 6.953898e-5 |
GO:0045666 | positive regulation of neuron differentiation | 7.131775e-5 |
GO:0042698 | ovulation cycle | 7.154355e-5 |
GO:0042445 | hormone metabolic process | 7.224949e-5 |
GO:0050851 | antigen receptor-mediated signaling pathway | 7.250660e-5 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 7.819565e-5 |
GO:0045838 | positive regulation of membrane potential | 7.931437e-5 |
GO:0002051 | osteoblast fate commitment | 8.112694e-5 |
GO:0050670 | regulation of lymphocyte proliferation | 8.115435e-5 |
GO:0035418 | protein localization to synapse | 8.791605e-5 |
GO:0032655 | regulation of interleukin-12 production | 8.991471e-5 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 9.065068e-5 |
GO:0021891 | olfactory bulb interneuron development | 9.752259e-5 |
GO:0001953 | negative regulation of cell-matrix adhesion | 9.845029e-5 |
GO:0034261 | negative regulation of Ras GTPase activity | 1.035201e-4 |
GO:0032944 | regulation of mononuclear cell proliferation | 1.054879e-4 |
GO:0002285 | lymphocyte activation involved in immune response | 1.060277e-4 |
GO:0045165 | cell fate commitment | 1.091890e-4 |
GO:0048598 | embryonic morphogenesis | 1.129284e-4 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 1.155611e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.178672e-4 |
GO:0035623 | renal glucose absorption | 1.178672e-4 |
GO:0045668 | negative regulation of osteoblast differentiation | 1.194605e-4 |
GO:0032695 | negative regulation of interleukin-12 production | 1.210902e-4 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1.210902e-4 |
GO:0030003 | cellular cation homeostasis | 1.228709e-4 |
GO:0048625 | myoblast cell fate commitment | 1.231369e-4 |
GO:0042127 | regulation of cell proliferation | 1.260400e-4 |
GO:0050926 | regulation of positive chemotaxis | 1.268401e-4 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 1.280526e-4 |
GO:0006875 | cellular metal ion homeostasis | 1.284996e-4 |
GO:0048762 | mesenchymal cell differentiation | 1.341646e-4 |
GO:0051640 | organelle localization | 1.349787e-4 |
GO:0050927 | positive regulation of positive chemotaxis | 1.353471e-4 |
GO:0072358 | cardiovascular system development | 1.365287e-4 |
GO:0050871 | positive regulation of B cell activation | 1.388284e-4 |
GO:0035690 | cellular response to drug | 1.427377e-4 |
GO:0018298 | protein-chromophore linkage | 1.440842e-4 |
GO:0070663 | regulation of leukocyte proliferation | 1.527269e-4 |
GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 1.532825e-4 |
GO:0001568 | blood vessel development | 1.586211e-4 |
GO:0002684 | positive regulation of immune system process | 1.595348e-4 |
GO:0001887 | selenium compound metabolic process | 1.599643e-4 |
GO:0050776 | regulation of immune response | 1.630043e-4 |
GO:0055078 | sodium ion homeostasis | 1.645308e-4 |
GO:0045596 | negative regulation of cell differentiation | 1.671848e-4 |
GO:0006098 | pentose-phosphate shunt | 1.704897e-4 |
GO:0060411 | cardiac septum morphogenesis | 1.721596e-4 |
GO:0014033 | neural crest cell differentiation | 1.735260e-4 |
GO:0001501 | skeletal system development | 1.770684e-4 |
GO:0008057 | eye pigment granule organization | 1.807403e-4 |
GO:0021889 | olfactory bulb interneuron differentiation | 1.850067e-4 |
GO:0006739 | NADP metabolic process | 1.866412e-4 |
GO:0030510 | regulation of BMP signaling pathway | 1.868152e-4 |
GO:0008354 | germ cell migration | 1.873779e-4 |
GO:0051250 | negative regulation of lymphocyte activation | 1.877530e-4 |
GO:0008585 | female gonad development | 1.877530e-4 |
GO:0048857 | neural nucleus development | 1.895497e-4 |
GO:0007420 | brain development | 1.931026e-4 |
GO:0042448 | progesterone metabolic process | 1.952847e-4 |
GO:0051586 | positive regulation of dopamine uptake | 1.975236e-4 |
GO:0060173 | limb development | 2.001985e-4 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 2.056558e-4 |
GO:0051971 | positive regulation of transmission of nerve impulse | 2.069943e-4 |
GO:0001525 | angiogenesis | 2.127792e-4 |
GO:0014031 | mesenchymal cell development | 2.225906e-4 |
GO:0045667 | regulation of osteoblast differentiation | 2.255247e-4 |
GO:0035810 | positive regulation of urine volume | 2.276007e-4 |
GO:0046851 | negative regulation of bone remodeling | 2.292332e-4 |
GO:0051650 | establishment of vesicle localization | 2.340834e-4 |
GO:0035108 | limb morphogenesis | 2.374935e-4 |
GO:0002682 | regulation of immune system process | 2.459638e-4 |
GO:0048854 | brain morphogenesis | 2.505573e-4 |
GO:0031290 | retinal ganglion cell axon guidance | 2.535815e-4 |
GO:0097070 | ductus arteriosus closure | 2.541260e-4 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 2.541260e-4 |
GO:0061039 | ovum-producing ovary development | 2.570691e-4 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 2.586209e-4 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 2.666105e-4 |
GO:0019725 | cellular homeostasis | 2.677635e-4 |
GO:0055013 | cardiac muscle cell development | 2.715112e-4 |
GO:0071380 | cellular response to prostaglandin E stimulus | 2.847468e-4 |
GO:0045595 | regulation of cell differentiation | 2.867849e-4 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 2.888061e-4 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 2.888061e-4 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 2.888061e-4 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.888061e-4 |
GO:0018149 | peptide cross-linking | 3.034246e-4 |
GO:0001941 | postsynaptic membrane organization | 3.079572e-4 |
GO:0001763 | morphogenesis of a branching structure | 3.083192e-4 |
GO:0003151 | outflow tract morphogenesis | 3.135145e-4 |
GO:0001952 | regulation of cell-matrix adhesion | 3.204247e-4 |
GO:0050921 | positive regulation of chemotaxis | 3.230277e-4 |
GO:0048514 | blood vessel morphogenesis | 3.248696e-4 |
GO:0003006 | developmental process involved in reproduction | 3.251114e-4 |
GO:0060134 | prepulse inhibition | 3.312365e-4 |
GO:0042113 | B cell activation | 3.376597e-4 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 3.565837e-4 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 3.763753e-4 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 3.772010e-4 |
GO:0000245 | spliceosome assembly | 3.795057e-4 |
GO:0000733 | DNA strand renaturation | 3.824231e-4 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 4.079185e-4 |
GO:0090074 | negative regulation of protein homodimerization activity | 4.079185e-4 |
GO:0033688 | regulation of osteoblast proliferation | 4.130509e-4 |
GO:0050778 | positive regulation of immune response | 4.132490e-4 |
GO:0010817 | regulation of hormone levels | 4.287881e-4 |
GO:0002764 | immune response-regulating signaling pathway | 4.542777e-4 |
GO:0097113 | alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering | 4.564869e-4 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 4.564869e-4 |
GO:0034104 | negative regulation of tissue remodeling | 4.577120e-4 |
GO:0006952 | defense response | 4.622698e-4 |
GO:0010749 | regulation of nitric oxide mediated signal transduction | 4.646540e-4 |
GO:0050806 | positive regulation of synaptic transmission | 4.658072e-4 |
GO:0030323 | respiratory tube development | 4.813491e-4 |
GO:0051607 | defense response to virus | 4.850990e-4 |
GO:0050891 | multicellular organismal water homeostasis | 4.884936e-4 |
GO:0001911 | negative regulation of leukocyte mediated cytotoxicity | 5.030486e-4 |
GO:0019320 | hexose catabolic process | 5.098351e-4 |
GO:0043032 | positive regulation of macrophage activation | 5.141473e-4 |
GO:0071305 | cellular response to vitamin D | 5.195060e-4 |
GO:0030324 | lung development | 5.201405e-4 |
GO:0042592 | homeostatic process | 5.307625e-4 |
GO:0031646 | positive regulation of neurological system process | 5.444800e-4 |
GO:0031342 | negative regulation of cell killing | 5.456346e-4 |
GO:0071559 | response to transforming growth factor beta stimulus | 5.461433e-4 |
GO:0043009 | chordate embryonic development | 5.507898e-4 |
GO:0002757 | immune response-activating signal transduction | 5.528570e-4 |
GO:0040017 | positive regulation of locomotion | 5.572941e-4 |
GO:0045659 | negative regulation of neutrophil differentiation | 5.665523e-4 |
GO:0006925 | inflammatory cell apoptosis | 5.665523e-4 |
GO:0046621 | negative regulation of organ growth | 5.668766e-4 |
GO:0009264 | deoxyribonucleotide catabolic process | 5.816484e-4 |
GO:0002009 | morphogenesis of an epithelium | 5.816940e-4 |
GO:0030183 | B cell differentiation | 5.835488e-4 |
GO:0060174 | limb bud formation | 5.854825e-4 |
GO:0033373 | maintenance of protease location in mast cell secretory granule | 6.186984e-4 |
GO:0033382 | maintenance of granzyme B location in T cell secretory granule | 6.186984e-4 |
GO:0033363 | secretory granule organization | 6.284954e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 6.362825e-4 |
GO:0055006 | cardiac cell development | 6.481305e-4 |
GO:0007548 | sex differentiation | 6.483190e-4 |
GO:0032825 | positive regulation of natural killer cell differentiation | 6.562360e-4 |
GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 6.619196e-4 |
GO:0072507 | divalent inorganic cation homeostasis | 6.678083e-4 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 6.703183e-4 |
GO:0046601 | positive regulation of centriole replication | 6.740060e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 6.757374e-4 |
GO:0045638 | negative regulation of myeloid cell differentiation | 6.784058e-4 |
GO:0065007 | biological regulation | 6.903524e-4 |
GO:0035909 | aorta morphogenesis | 6.931260e-4 |
GO:0050864 | regulation of B cell activation | 6.964585e-4 |
GO:0043603 | cellular amide metabolic process | 7.016262e-4 |
GO:0006007 | glucose catabolic process | 7.065815e-4 |
GO:0055074 | calcium ion homeostasis | 7.121679e-4 |
GO:0010627 | regulation of intracellular protein kinase cascade | 7.138931e-4 |
GO:0051272 | positive regulation of cellular component movement | 7.208491e-4 |
GO:0060563 | neuroepithelial cell differentiation | 7.268526e-4 |
GO:0001841 | neural tube formation | 7.312399e-4 |
GO:0002011 | morphogenesis of an epithelial sheet | 7.355984e-4 |
GO:0032816 | positive regulation of natural killer cell activation | 7.593452e-4 |
GO:0002253 | activation of immune response | 7.938749e-4 |
GO:0071377 | cellular response to glucagon stimulus | 8.058168e-4 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 8.058168e-4 |
GO:0002066 | columnar/cuboidal epithelial cell development | 8.099970e-4 |
GO:0060485 | mesenchyme development | 8.113649e-4 |
GO:0031424 | keratinization | 8.428539e-4 |
GO:0009792 | embryo development ending in birth or egg hatching | 8.476739e-4 |
GO:0050679 | positive regulation of epithelial cell proliferation | 8.628320e-4 |
GO:0006953 | acute-phase response | 8.631239e-4 |
GO:0050678 | regulation of epithelial cell proliferation | 8.721166e-4 |
GO:0046365 | monosaccharide catabolic process | 8.882295e-4 |
GO:0043652 | engulfment of apoptotic cell | 8.898030e-4 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.037366e-4 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 9.135911e-4 |
GO:0035809 | regulation of urine volume | 9.281942e-4 |
GO:0015871 | choline transport | 9.454983e-4 |
GO:0044275 | cellular carbohydrate catabolic process | 9.458535e-4 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 9.460145e-4 |
GO:0023056 | positive regulation of signaling | 9.548398e-4 |
GO:0030335 | positive regulation of cell migration | 9.864941e-4 |
GO:0002637 | regulation of immunoglobulin production | 9.929170e-4 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 9.981988e-4 |
GO:0032252 | secretory granule localization | 1.014921e-3 |
GO:0001822 | kidney development | 1.066484e-3 |
GO:0050701 | interleukin-1 secretion | 1.088331e-3 |
GO:0045062 | extrathymic T cell selection | 1.088331e-3 |
GO:0071675 | regulation of mononuclear cell migration | 1.102414e-3 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 1.103331e-3 |
GO:0051387 | negative regulation of nerve growth factor receptor signaling pathway | 1.110229e-3 |
GO:0008535 | respiratory chain complex IV assembly | 1.110229e-3 |
GO:0051918 | negative regulation of fibrinolysis | 1.123381e-3 |
GO:0071773 | cellular response to BMP stimulus | 1.135334e-3 |
GO:0060429 | epithelium development | 1.150316e-3 |
GO:0002312 | B cell activation involved in immune response | 1.158477e-3 |
GO:0045663 | positive regulation of myoblast differentiation | 1.171131e-3 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.186152e-3 |
GO:0003300 | cardiac muscle hypertrophy | 1.209050e-3 |
GO:0045058 | T cell selection | 1.250901e-3 |
GO:0044344 | cellular response to fibroblast growth factor stimulus | 1.267248e-3 |
GO:0010955 | negative regulation of protein processing | 1.269766e-3 |
GO:0035904 | aorta development | 1.273228e-3 |
GO:0060079 | regulation of excitatory postsynaptic membrane potential | 1.277084e-3 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 1.317551e-3 |
GO:0003207 | cardiac chamber formation | 1.317551e-3 |
GO:0032612 | interleukin-1 production | 1.321950e-3 |
GO:0003279 | cardiac septum development | 1.326543e-3 |
GO:2000147 | positive regulation of cell motility | 1.326563e-3 |
GO:0003014 | renal system process | 1.334301e-3 |
GO:0035282 | segmentation | 1.341574e-3 |
GO:0032755 | positive regulation of interleukin-6 production | 1.355842e-3 |
GO:0070848 | response to growth factor stimulus | 1.358775e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.360244e-3 |
GO:0050767 | regulation of neurogenesis | 1.366831e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 1.369102e-3 |
GO:0045577 | regulation of B cell differentiation | 1.398643e-3 |
GO:0006879 | cellular iron ion homeostasis | 1.398643e-3 |
GO:2000270 | negative regulation of fibroblast apoptosis | 1.407714e-3 |
GO:2000271 | positive regulation of fibroblast apoptosis | 1.407714e-3 |
GO:2000080 | negative regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 1.407714e-3 |
GO:0044345 | stromal-epithelial cell signaling involved in prostate gland development | 1.407714e-3 |
GO:0021570 | rhombomere 4 development | 1.407714e-3 |
GO:0006915 | apoptosis | 1.410997e-3 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 1.415827e-3 |
GO:0015939 | pantothenate metabolic process | 1.466671e-3 |
GO:0006911 | phagocytosis, engulfment | 1.509500e-3 |
GO:0051094 | positive regulation of developmental process | 1.525601e-3 |
GO:0016052 | carbohydrate catabolic process | 1.544205e-3 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 1.589184e-3 |
GO:0015867 | ATP transport | 1.595165e-3 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 1.596681e-3 |
GO:0015721 | bile acid and bile salt transport | 1.627653e-3 |
GO:0001932 | regulation of protein phosphorylation | 1.634259e-3 |
GO:0032103 | positive regulation of response to external stimulus | 1.639128e-3 |
GO:0010810 | regulation of cell-substrate adhesion | 1.656093e-3 |
GO:0043030 | regulation of macrophage activation | 1.673625e-3 |
GO:0048699 | generation of neurons | 1.678368e-3 |
GO:0046078 | dUMP metabolic process | 1.709829e-3 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 1.709829e-3 |
GO:0051960 | regulation of nervous system development | 1.721818e-3 |
GO:0040011 | locomotion | 1.730089e-3 |
GO:0001757 | somite specification | 1.761615e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.764099e-3 |
GO:0009605 | response to external stimulus | 1.783331e-3 |
GO:0055024 | regulation of cardiac muscle tissue development | 1.813115e-3 |
GO:0021915 | neural tube development | 1.817821e-3 |
GO:0070293 | renal absorption | 1.839915e-3 |
GO:0002695 | negative regulation of leukocyte activation | 1.842778e-3 |
GO:0051883 | killing of cells in other organism involved in symbiotic interaction | 1.868783e-3 |
GO:0003357 | noradrenergic neuron differentiation | 1.868783e-3 |
GO:0030901 | midbrain development | 1.873212e-3 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 1.880528e-3 |
GO:0046631 | alpha-beta T cell activation | 1.886801e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 1.902748e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 1.923738e-3 |
GO:0016202 | regulation of striated muscle tissue development | 1.927005e-3 |
GO:0030001 | metal ion transport | 1.941903e-3 |
GO:0046164 | alcohol catabolic process | 1.945060e-3 |
GO:0034695 | response to prostaglandin E stimulus | 1.945430e-3 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 1.955496e-3 |
GO:0048608 | reproductive structure development | 1.979691e-3 |
GO:0015908 | fatty acid transport | 1.983391e-3 |
GO:0030889 | negative regulation of B cell proliferation | 1.986910e-3 |
GO:0070365 | hepatocyte differentiation | 1.989952e-3 |
GO:2000079 | regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation | 2.020242e-3 |
GO:0048634 | regulation of muscle organ development | 2.051460e-3 |
GO:0031640 | killing of cells of other organism | 2.059864e-3 |
GO:0060554 | induction of necroptosis of activated-T cells | 2.085925e-3 |
GO:0071842 | cellular component organization at cellular level | 2.088302e-3 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 2.110539e-3 |
GO:0006700 | C21-steroid hormone biosynthetic process | 2.127170e-3 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 2.146925e-3 |
GO:0051186 | cofactor metabolic process | 2.153838e-3 |
GO:0002326 | B cell lineage commitment | 2.204957e-3 |
GO:0050777 | negative regulation of immune response | 2.215215e-3 |
GO:0031399 | regulation of protein modification process | 2.219095e-3 |
GO:0051893 | regulation of focal adhesion assembly | 2.238041e-3 |
GO:0072001 | renal system development | 2.239810e-3 |
GO:0048518 | positive regulation of biological process | 2.242759e-3 |
GO:0012501 | programmed cell death | 2.258539e-3 |
GO:0010758 | regulation of macrophage chemotaxis | 2.267261e-3 |
GO:0051584 | regulation of dopamine uptake | 2.280044e-3 |
GO:0002309 | T cell proliferation involved in immune response | 2.280044e-3 |
GO:0006302 | double-strand break repair | 2.365783e-3 |
GO:0060078 | regulation of postsynaptic membrane potential | 2.382920e-3 |
GO:0051917 | regulation of fibrinolysis | 2.387917e-3 |
GO:0001542 | ovulation from ovarian follicle | 2.395290e-3 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 2.413233e-3 |
GO:0061337 | cardiac conduction | 2.418585e-3 |
GO:0048468 | cell development | 2.426998e-3 |
GO:0006477 | protein sulfation | 2.427724e-3 |
GO:0034453 | microtubule anchoring | 2.433525e-3 |
GO:0010812 | negative regulation of cell-substrate adhesion | 2.451788e-3 |
GO:0003211 | cardiac ventricle formation | 2.466352e-3 |
GO:0051656 | establishment of organelle localization | 2.499111e-3 |
GO:0055062 | phosphate ion homeostasis | 2.508166e-3 |
GO:0045670 | regulation of osteoclast differentiation | 2.509975e-3 |
GO:0030890 | positive regulation of B cell proliferation | 2.526291e-3 |
GO:0001890 | placenta development | 2.534698e-3 |
GO:0060402 | calcium ion transport into cytosol | 2.553494e-3 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.562526e-3 |
GO:0035239 | tube morphogenesis | 2.564625e-3 |
GO:0022008 | neurogenesis | 2.597732e-3 |
GO:0044087 | regulation of cellular component biogenesis | 2.617390e-3 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 2.618628e-3 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 2.618628e-3 |
GO:0061141 | lung ciliated cell differentiation | 2.618628e-3 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 2.618628e-3 |
GO:0010757 | negative regulation of plasminogen activation | 2.618628e-3 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 2.657561e-3 |
GO:0043113 | receptor clustering | 2.695434e-3 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 2.695736e-3 |
GO:0055075 | potassium ion homeostasis | 2.702338e-3 |
GO:0045992 | negative regulation of embryonic development | 2.736236e-3 |
GO:0035587 | purinergic receptor signaling pathway | 2.739945e-3 |
GO:0002360 | T cell lineage commitment | 2.746180e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.800484e-3 |
GO:0045329 | carnitine biosynthetic process | 2.814433e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 2.830544e-3 |
GO:0008105 | asymmetric protein localization | 2.858939e-3 |
GO:0010755 | regulation of plasminogen activation | 2.864601e-3 |
GO:0034260 | negative regulation of GTPase activity | 2.864601e-3 |
GO:0006529 | asparagine biosynthetic process | 2.984711e-3 |
GO:0010647 | positive regulation of cell communication | 2.996751e-3 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 2.998407e-3 |
GO:0015868 | purine ribonucleotide transport | 3.050952e-3 |
GO:0071363 | cellular response to growth factor stimulus | 3.076644e-3 |
GO:0051149 | positive regulation of muscle cell differentiation | 3.121174e-3 |
GO:0035136 | forelimb morphogenesis | 3.129750e-3 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 3.153913e-3 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 3.153981e-3 |
GO:0071955 | recycling endosome to Golgi transport | 3.153981e-3 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 3.153981e-3 |
GO:0034499 | late endosome to Golgi transport | 3.153981e-3 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 3.153981e-3 |
GO:0001964 | startle response | 3.169556e-3 |
GO:0015718 | monocarboxylic acid transport | 3.176448e-3 |
GO:0042573 | retinoic acid metabolic process | 3.223381e-3 |
GO:0097114 | N-methyl-D-aspartate receptor clustering | 3.232242e-3 |
GO:0097117 | guanylate kinase-associated protein clustering | 3.232242e-3 |
GO:0097112 | gamma-aminobutyric acid receptor clustering | 3.232242e-3 |
GO:0001915 | negative regulation of T cell mediated cytotoxicity | 3.256882e-3 |
GO:0031065 | positive regulation of histone deacetylation | 3.282362e-3 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 3.294919e-3 |
GO:0014009 | glial cell proliferation | 3.303199e-3 |
GO:0050671 | positive regulation of lymphocyte proliferation | 3.312176e-3 |
GO:0008340 | determination of adult lifespan | 3.363691e-3 |
GO:0006903 | vesicle targeting | 3.406681e-3 |
GO:0002526 | acute inflammatory response | 3.407095e-3 |
GO:0006376 | mRNA splice site selection | 3.447094e-3 |
GO:0008211 | glucocorticoid metabolic process | 3.447094e-3 |
GO:0035117 | embryonic arm morphogenesis | 3.457993e-3 |
GO:0051896 | regulation of protein kinase B signaling cascade | 3.475309e-3 |
GO:0001654 | eye development | 3.486956e-3 |
GO:0001655 | urogenital system development | 3.516776e-3 |
GO:0046826 | negative regulation of protein export from nucleus | 3.521320e-3 |
GO:0055021 | regulation of cardiac muscle tissue growth | 3.522777e-3 |
GO:0043576 | regulation of respiratory gaseous exchange | 3.527430e-3 |
GO:0060040 | retinal bipolar neuron differentiation | 3.555943e-3 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 3.555943e-3 |
GO:0033625 | positive regulation of integrin activation | 3.555943e-3 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 3.555943e-3 |
GO:0060420 | regulation of heart growth | 3.682873e-3 |
GO:0071481 | cellular response to X-ray | 3.735505e-3 |
GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response | 3.820867e-3 |
GO:0008406 | gonad development | 3.830394e-3 |
GO:0045590 | negative regulation of regulatory T cell differentiation | 3.845394e-3 |
GO:0044065 | regulation of respiratory system process | 3.942572e-3 |
GO:0014888 | striated muscle adaptation | 3.963798e-3 |
GO:0007220 | Notch receptor processing | 3.975524e-3 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 3.979703e-3 |
GO:0002087 | regulation of respiratory gaseous exchange by neurological system process | 3.979703e-3 |
GO:0050866 | negative regulation of cell activation | 4.026450e-3 |
GO:0048806 | genitalia development | 4.035879e-3 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 4.037009e-3 |
GO:0045137 | development of primary sexual characteristics | 4.100514e-3 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 4.167281e-3 |